Menquadfi vial 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F0A6H
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $69,014
Award facts
- Contract value 100% obligated
- $69,013.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $69,013.84 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Menquadfi vials (0.5mL) with a completion deadline of January 29, 2026. This non-set-aside contract was competitively awarded and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The order represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999.99 million through December 2026), which serves as a comprehensive pharmaceutical supply vehicle for military and federal healthcare systems worldwide. AmerisourceBergen, now operating under its parent company Cencora, Inc., is a major pharmaceutical distributor serving critical federal medical procurement needs.
This delivery order supports DLA's medical supply chain operations, which provide pharmaceutical products and medical supplies to Defense Health Agency facilities, the U.S. Coast Guard, and other government healthcare systems. Menquadfi (meningococcal group B vaccine) is a critical immunological product used in military medical readiness programs. The firm fixed-price structure and competitive award reflect standard federal procurement practices for pharmaceutical commodities through established prime vendor contracts, demonstrating AmerisourceBergen's demonstrated capability to meet federal government medical supply requirements in an open competitive environment.
Quick answers
Who was awarded contract SPE2DR26F0A6H?
SPE2DR26F0A6H was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26F0A6H worth?
The government has obligated $69,014 on SPE2DR26F0A6H.
Is contract SPE2DR26F0A6H an order under another contract?
Yes. SPE2DR26F0A6H is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F0A6H competed?
The extent of competition for SPE2DR26F0A6H was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award